赛诺菲
Search documents
美股前瞻|三大股指期货齐跌 美股12月24日提前休市,12月25日休市一日
Jin Rong Jie· 2025-12-24 13:45
Market Overview - US stock index futures are all down ahead of the market opening on December 24, with Dow futures down 0.08%, S&P 500 futures down 0.02%, and Nasdaq futures down 0.01% [1] - European indices show mixed performance, with Germany's DAX up 0.23%, UK's FTSE 100 down 0.26%, France's CAC40 up 0.10%, and the Euro Stoxx 50 up 0.14% [1] Commodity Prices - WTI crude oil is up 0.26%, priced at $58.53 per barrel, while Brent crude oil is up 0.11%, priced at $62.45 per barrel [2] Market Events - US stock markets will close early on December 24 and remain closed on December 25 due to the Christmas holiday. Various futures contracts will also have adjusted trading hours [3] Economic Insights - US Treasury Secretary Scott Bentsen suggests discussing a potential adjustment of the Federal Reserve's 2% inflation target to a range of 1.5% to 2.5% or 1% to 3% once inflation sustainably returns to 2% [4] - White House economic advisor Kevin Hassett indicates that the US economy is recovering strongly, with GDP growth potentially remaining around 4%, which could lead to increased job growth [4] Pharmaceutical Developments - Sanofi has agreed to acquire Dynavax Technologies for approximately $2.2 billion to expand its vaccine portfolio, offering $15.50 per share, a 39% premium over Dynavax's closing price [7] Energy Sector Movements - BP has agreed to sell a 65% stake in its Castrol lubricants business to Stonepeak Partners for about $6 billion, part of a larger $20 billion asset divestment plan [8] Technology Sector Updates - Meta faces antitrust pressure in Italy, with the Italian antitrust authority ordering the suspension of certain contract terms that may exclude competitors' AI chatbots from WhatsApp [9] - The US Department of Defense plans to integrate xAI's Grok AI models into its military AI service platform by early 2026, enhancing operational capabilities [10]
Futures Flat With Early Close On Deck
ZeroHedge· 2025-12-24 13:29
Market Overview - The S&P 500 reached a new record high, buoyed by investor confidence in corporate earnings growth and easing inflation for 2026, alongside the Federal Reserve's QE Lite injecting $40 billion into the market [1] - The VIX index remains low, indicating calm in equities, with no down month since April [1] - Precious metals, including gold, silver, and platinum, have hit record highs, driven by geopolitical concerns and expectations for interest rate cuts in 2026 [6][13] Corporate News - Sanofi agreed to acquire Dynavax Technologies for approximately $2.2 billion, aiming to expand its vaccine business [3][10] - Nike shares rose by 2.1% after Apple CEO Tim Cook purchased $2.95 million worth of Nike stock [1][5] - Intel shares fell by 3.2% following reports that Nvidia halted a test using Intel's technology [5][10] Economic Indicators - The latest MBA Mortgage Applications decreased by 5.0%, indicating a potential slowdown in the housing market [1] - Initial jobless claims are expected to be around 223,000, reflecting ongoing labor market conditions [29] Commodity Market - Gold prices reached $4,500 per ounce for the first time, while silver and platinum also surged to all-time highs, marking their best yearly gains since 1979 [6][8] - Copper prices hit a new record of approximately $12,200 per ton, set for its largest annual rise since 2009 [6][13]
盘前:纳指期货跌0.01% 今日美股提前三小时休市
Xin Lang Cai Jing· 2025-12-24 13:19
Market Overview - Global stock markets are trading moderately, with European stocks mostly flat and US stocks hovering near historical highs ahead of the Christmas holiday [2][19] - The S&P 500 index futures are flat, while the Dow Jones and Nasdaq futures show slight declines [3][20] - The European Stoxx 600 index remains stable, boosted by Novo Nordisk's stock surge after FDA approval of its first GLP-1 pill, which contributed to a record closing high [3][20] Economic Indicators - Investor confidence is supported by the US economy's continued outperformance, which bolsters corporate profit outlooks for the coming year [3][20] - The market anticipates at least two rate cuts by the Federal Reserve by 2026, which could further support broader stock sectors despite concerns over high valuations in leading tech stocks [3][20] Precious Metals - Gold prices surged above $4,500 per ounce, driven by heightened geopolitical tensions in Venezuela and expectations of interest rate cuts, although some gains were later retraced [5][22] - Platinum also reached a historical high before pulling back, reflecting similar trends in the precious metals market [5][22] Oil Market - Oil prices continue to rise due to escalating tensions surrounding Venezuela, marking the largest five-day increase since October 27 and the longest consecutive rise since March 27 [6][22] - Brent crude oil increased by 0.4% to $62.14 per barrel, while WTI crude rose by 0.6% to $58.71 per barrel, with a cumulative increase of 5.87% over the past five days [6][22] Currency and Debt Markets - The US dollar has fallen for three consecutive days, expanding its year-to-date decline to 8.4%, as it approaches an 11-week low [7][24] - The 10-year US Treasury yield is stable around 4.16%, with recent economic data showing a 4.3% annualized growth rate for Q3, which initially supported yields [8][26] Corporate Highlights - Intel shares dropped over 5% in pre-market trading due to news that Nvidia has paused testing its 18A process technology [29] - Nike shares rose 2.4% after Apple CEO Tim Cook purchased 50,000 shares [30] - UiPath shares increased by 6.6% after being added to the S&P MidCap 400 index [31] - Sanofi's acquisition of Denali Therapeutics for approximately $2.2 billion led to a surge of over 37% in Denali's stock [31]
美股盘前要点|美股平安夜将提前休市 传英伟达暂停测试英特尔18A制程
Jin Rong Jie· 2025-12-24 13:06
9. 苹果CEO库克周一"逢低买入"5万股耐克股票,交易金额接近300万美元。 10. 波音获美国空军授予一份价值20亿美元的合同,旨在推进B-52项目。 1. 美国三大股指期货小幅下跌,纳指期货跌0.01%,标普500指数期货跌0.02%,道指期货跌0.07%。 2. 美股今日提前3小时休市(提前于北京时间25日02:00休市),圣诞节(周四)美股休市1日。 3. 穆迪:剔除技术性因素影响,美国第三季基础实质GDP增长约2%。 4. 知情人士称英伟达已暂停对英特尔18A制程工艺的测试。 5. 摩根大通:苹果iPhone 17系列交货前置时间明显缩短,供需状况正趋于稳定。 6. 苹果与巴西反垄断机构和解,将开放第三方应用商店。 7. 赛诺菲拟斥约22亿美元收购德纳维制药,旨在扩充疫苗产品线。 8. 华纳兄弟探索关键股东:派拉蒙修改后的条件仍不够好,将继续观望。 11. 洛克希德马丁获美国国防部将一项涉及C-130J运输机的合同总金额提高至250亿美元。 12. 英国石油接近以100亿美元将嘉实多(Castrol)润滑油业务的多数股权出售给Stonepeak。 13. 自动化企业UiPath获纳入标普中型股40 ...
美股前瞻 | 三大股指期货齐跌,美股12月24日提前休市,12月25日休市一日
Zhi Tong Cai Jing· 2025-12-24 12:59
Market Overview - US stock index futures are all down ahead of the market opening on December 24, with Dow futures down 0.08%, S&P 500 futures down 0.02%, and Nasdaq futures down 0.01% [1] - European indices show mixed performance, with Germany's DAX up 0.23%, UK's FTSE 100 down 0.26%, France's CAC 40 up 0.10%, and the Euro Stoxx 50 up 0.14% [2][3] - WTI crude oil is up 0.26% at $58.53 per barrel, while Brent crude is up 0.11% at $62.45 per barrel [3][4] Economic Events and Policies - The US plans to impose tariffs on China's semiconductor industry starting in 2027, which China opposes, stating it disrupts global supply chains [5] - US Treasury Secretary supports discussing a potential adjustment of the Federal Reserve's 2% inflation target to a range of 1.5% to 2.5% or 1% to 3% [5] - Economic growth data indicates a strong recovery, with expectations of job growth returning to 100,000 to 150,000 range if GDP growth remains around 4% [6] Company News - Apple CEO Tim Cook purchased $2.95 million worth of Nike stock, leading to a pre-market increase of over 2% for Nike [8] - Sanofi is acquiring Dynavax Technologies for approximately $2.2 billion to expand its vaccine portfolio, offering a 39% premium over Dynavax's closing price [9] - BP is selling a 65% stake in its Castrol lubricants business for about $6 billion as part of a larger asset divestment plan [10] - Meta faces antitrust pressure in Italy, with the Italian antitrust authority ordering a suspension of certain contract terms that may exclude competitors from WhatsApp [11] - xAI's Grok AI models will be integrated into the US Department of Defense's AI platform, expected to enhance operational capabilities [12]
美股盘前要点 | 平安夜美股将提前休市,传英伟达暂停测试英特尔18A制程
Xin Lang Cai Jing· 2025-12-24 12:40
Group 1 - US stock index futures showed slight declines, with Nasdaq futures down 0.01%, S&P 500 futures down 0.02%, and Dow futures down 0.07% [1] - Moody's reported that the US real GDP growth for Q3 is approximately 2% after excluding technical factors [4] - Nvidia has reportedly paused testing of Intel's 18A process technology [5] - Morgan Stanley noted that the delivery lead times for Apple's iPhone 17 series have significantly shortened, indicating a stabilizing supply-demand situation [5] Group 2 - Apple reached a settlement with Brazil's antitrust agency, allowing the opening of third-party app stores [2] - Sanofi plans to acquire Denali Therapeutics for approximately $2.2 billion to expand its vaccine product line [8] - Warner Bros. Discovery's key shareholders stated that Paramount's revised conditions are still not satisfactory and will continue to observe [9] - Apple CEO Tim Cook purchased 50,000 shares of Nike stock for nearly $3 million [10] Group 3 - Boeing received a $2 billion contract from the US Air Force to advance the B-52 program [11] - Lockheed Martin's contract with the US Department of Defense for the C-130J transport aircraft has been increased to a total of $25 billion [12] - BP is nearing a $10 billion deal to sell a majority stake in its Castrol lubricants business to Stonepeak [13] - Automation company UiPath will be included in the S&P MidCap 400 index, effective before the market opens on January 6 [14] Group 4 - Notable event during US trading hours: Initial jobless claims for the week ending December 20 [8]
美股盘前要点 | 美股平安夜将提前休市,传英伟达暂停测试英特尔18A制程
Ge Long Hui· 2025-12-24 12:35
Group 1 - U.S. stock index futures are slightly down, with Nasdaq futures down 0.01%, S&P 500 futures down 0.02%, and Dow futures down 0.07% [1] - Moody's reports that the U.S. real GDP growth for Q3 is approximately 2% after excluding technical factors [4] - Nvidia has reportedly paused testing of Intel's 18A process technology [5] - Morgan Stanley indicates that the delivery lead times for Apple's iPhone 17 series have significantly shortened, with supply and demand conditions stabilizing [6] - Apple has reached a settlement with Brazil's antitrust agency, allowing third-party app stores [7] - Sanofi plans to acquire Denali Therapeutics for approximately $2.2 billion to expand its vaccine product line [8] - Warner Bros. Discovery's key shareholder, Paramount, finds the revised conditions insufficient and will continue to observe [9] - Boeing has been awarded a $2 billion contract by the U.S. Air Force to advance the B-52 program [11] - Lockheed Martin has received an increase in the total contract amount from the U.S. Department of Defense for the C-130J transport aircraft to $25 billion [12] - BP is nearing a $10 billion sale of a majority stake in Castrol lubricants business to Stonepeak [13] - UiPath has been added to the S&P MidCap 400 index, effective before the market opens on January 6 [14]
Sanofi to acquire Dynavax for $2.2B, sending shares higher by 37%
Invezz· 2025-12-24 11:49
Shares of Dynavax Technologies jumped sharply in premarket trading on Wednesday after the US vaccine maker agreed to be acquired by French pharmaceutical group Sanofi in an all-cash deal valued at abo... ...
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
Yahoo Finance· 2025-12-24 11:48
Acquisition Details - Sanofi will acquire Dynavax Technologies for approximately $2.2 billion (1.9 billion euros), gaining access to an approved hepatitis B vaccine [1] - The acquisition price is set at $15.50 per share, representing a 39% premium over Dynavax's closing price of $11.13 [3] - Sanofi expects to finalize the acquisition in the first quarter of 2026 and will utilize available cash for the transaction [3] Strategic Context - This acquisition is part of Sanofi's strategy to diversify growth beyond its leading asthma drug Dupixent, following other significant acquisitions in 2023, including Vicebio for $1.5 billion and BluePrint Medicines for up to $9.5 billion [2] - The deal is aimed at expanding Sanofi's vaccine portfolio amid declining vaccination rates in the U.S. and recent policy changes affecting vaccine funding and recommendations [4][5] Market Implications - The acquisition will provide Sanofi with access to an experimental shingles vaccine currently in early-stage testing, which analysts believe could enhance the company's market position [6] - The shingles vaccine market is significant, with GSK's Shringix projected to achieve sales of 4 billion euros this year [6] Regulatory Challenges - Separately, Sanofi faced a setback as the U.S. FDA declined to approve its experimental drug tolebrutinib for multiple sclerosis, highlighting ongoing regulatory challenges for the company [7]
Sanofi To Buy Vaccine Maker Dynavax For $2.2 Billion
Investors· 2025-12-24 12:09
Group 1 - The article does not contain any relevant content regarding companies or industries [1][2][3][4][5][6]